Development of inducible EIAV-based lentiviral vector packaging and producer cell lines (original) (raw)

• Mazarakis ND, Azzouz M, Rohll JB, Ellard FM, Wilkes FJ, Olsen AL et al. Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum Mol Genet 2001; 10: 2109–2121.
  Article CAS PubMed Google Scholar
• Mitrophanous K, Yoon S, Rohll J, Patil D, Wilkes F, Kim V et al. Stable gene transfer to the nervous system using a non-primate lentiviral vector. Gene Therapy 1999; 6: 1808–1818.
  Article CAS PubMed Google Scholar
• Mselli-Lakhal L, Guiguen F, Greenland T, Mornex JF, Chebloune Y . Gene transfer system derived from the caprine arthritis-encephalitis lentivirus. J Virol Methods 2006; 136: 177–184.
  Article CAS PubMed Google Scholar
• Poeschla EM, Wong-Staal F, Looney DJ . Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat Med 1998; 4: 354–357.
  Article CAS PubMed Google Scholar
• Takahashi K, Luo T, Saishin Y, Saishin Y, Sung J, Hackett S et al. Sustained transduction of ocular cells with a bovine immunodeficiency viral vector. Hum Gene Ther 2002; 13: 1305–1316.
  Article CAS PubMed Google Scholar
• Azzouz M, Martin-Rendon E, Barber RD, Mitrophanous KA, Carter EE, Rohll JB et al. Multicistronic lentiviral vector-mediated striatal gene transfer of aromatic L-amino acid decarboxylase, tyrosine hydroxylase, and GTP cyclohydrolase I induces sustained transgene expression, dopamine production, and functional improvement in a rat model of Parkinson's disease. J Neurosci 2002; 22: 10302–10312.
  Article CAS PubMed PubMed Central Google Scholar
• Azzouz M, Mazarakis N . Non-primate EIAV-based lentiviral vectors as gene delivery system for motor neuron diseases. Curr Gene Ther 2004; 4: 277–286.
  Article CAS PubMed Google Scholar
• Azzouz M, Ralph S, Wong LF, Day D, Askham Z, Barber RD et al. Neuroprotection in a rat Parkinson model by GDNF gene therapy using EIAV vector. Neuroreport 2004; 15: 985–990.
  Article CAS PubMed Google Scholar
• Balaggan KS, Binley K, Esapa M, MacLaren RE, Iqball S, Duran Y et al. EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNV. Gene Therapy 2006; 13: 1153–1165.
  Article CAS PubMed Google Scholar
• Bienemann AS, Martin-Rendon E, Cosgrave AS, Glover CP, Wong LF, Kingsman SM et al. Long-term replacement of a mutated nonfunctional CNS gene: reversal of hypothalamic diabetes insipidus using an EIAV-based lentiviral vector expressing arginine vasopressin. Mol Ther 2003; 7: 588–596.
  Article CAS PubMed Google Scholar
• Kong J, Kim SR, Binley K, Pata I, Doi K, Mannik J et al. Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy. Gene Therapy 2008; 15: 1311–1320.
  Article CAS PubMed PubMed Central Google Scholar
• Radcliffe PA, Sion CJ, Wilkes FJ, Custard EJ, Beard GL, Kingsman SM et al. Analysis of factor VIII mediated suppression of lentiviral vector titres. Gene Therapy 2008; 15: 289–297.
  Article CAS PubMed Google Scholar
• Ralph GS, Binley K, Wong LF, Azzouz M, Mazarakis ND . Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors. Clin Sci (Lond) 2006; 110: 37–46.
  Article CAS Google Scholar
• Broussau S, Jabbour N, Lachapelle G, Durocher Y, Tom R, Transfiguracion J et al. Inducible packaging cells for large-scale production of lentiviral vectors in serum-free suspension culture. Mol Ther 2008; 16: 500–507.
  Article CAS PubMed Google Scholar
• Cockrell AS, Ma H, Fu K, McCown TJ, Kafri T . A trans-lentiviral packaging cell line for high-titer conditional self-inactivating HIV-1 vectors. Mol Ther 2006; 14: 276–284.
  Article CAS PubMed Google Scholar
• Farson D, Witt R, McGuinness R, Dull T, Kelly M, Song J et al. A new-generation stable inducible packaging cell line for lentiviral vectors. Hum Gene Ther 2001; 12: 981–997.
  Article CAS PubMed Google Scholar
• Ikeda Y, Takeuchi Y, Martin F, Cosset FL, Mitrophanous K, Collins M . Continuous high-titer HIV-1 vector production. Nat Biotechnol 2003; 21: 569–572.
  Article CAS PubMed Google Scholar
• Kafri T, van Praag H, Ouyang L, Gage FH, Verma IM . A packaging cell line for lentivirus vectors. J Virol 1999; 73: 576–584.
  CAS PubMed PubMed Central Google Scholar
• Kaul M, Yu H, Ron Y, Dougherty JP . Regulated lentiviral packaging cell line devoid of most viral cis-acting sequences. Virology 1998; 249: 167–174.
  Article CAS PubMed Google Scholar
• Klages N, Zufferey R, Trono D . A stable system for the high-titer production of multiply attenuated lentiviral vectors. Mol Ther 2000; 2: 170–176.
  Article CAS PubMed Google Scholar
• Ni Y, Sun S, Oparaocha I, Humeau L, Davis B, Cohen R et al. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector. J Gene Med 2005; 7: 818–834.
  Article CAS PubMed Google Scholar
• Pacchia AL, Adelson ME, Kaul M, Ron Y, Dougherty JP . An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins. Virology 2001; 282: 77–86.
  Article CAS PubMed Google Scholar
• Sparacio S, Pfeiffer T, Schaal H, Bosch V . Generation of a flexible cell line with regulatable, high-level expression of HIV Gag/Pol particles capable of packaging HIV-derived vectors. Mol Ther 2001; 3: 602–612.
  Article CAS PubMed Google Scholar
• Xu K, Ma H, McCown TJ, Verma IM, Kafri T . Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors. Mol Ther 2001; 3: 97–104.
  Article CAS PubMed Google Scholar
• Yu H, Rabson AB, Kaul M, Ron Y, Dougherty JP . Inducible human immunodeficiency virus type 1 packaging cell lines. J Virol 1996; 70: 4530–4537.
  CAS PubMed PubMed Central Google Scholar
• Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK . Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 1993; 90: 8033–8037.
  Article CAS PubMed PubMed Central Google Scholar
• Cronin J, Zhang XY, Reiser J . Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther 2005; 5: 387–398.
  Article CAS PubMed PubMed Central Google Scholar
• DePolo NJ, Reed JD, Sheridan PL, Townsend K, Sauter SL, Jolly DJ et al. VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum. Mol Ther 2000; 2: 218–222.
  Article CAS PubMed Google Scholar
• Yee JK, Miyanohara A, LaPorte P, Bouic K, Burns JC, Friedmann T . A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc Natl Acad Sci USA 1994; 91: 9564–9568.
  Article CAS PubMed PubMed Central Google Scholar
• Gossen M, Bujard H . Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 89: 5547–5551.
  Article CAS PubMed PubMed Central Google Scholar
• Shockett P, Difilippantonio M, Hellman N, Schatz DG . A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc Natl Acad Sci USA 1995; 92: 6522–6526.
  Article CAS PubMed PubMed Central Google Scholar
• Yao F, Svensjo T, Winkler T, Lu M, Eriksson C, Eriksson E . Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulates inducible gene expression in mammalian cells. Hum Gene Ther 1998; 9: 1939–1950.
  Article CAS PubMed Google Scholar
• Hillen W, Berens C . Mechanisms underlying expression of Tn10 encoded tetracycline resistance. Annu Rev Microbiol 1994; 48: 345–369.
  Article CAS PubMed Google Scholar
• Carrondo MJ, Merten OW, Haury M, Alves PM, Coroadinha AS . Impact of retroviral vector components stoichiometry on packaging cell lines: effects on productivity and vector quality. Hum Gene Ther 2008; 19: 199–210.
  Article CAS PubMed Google Scholar
• Yap MW, Kingsman SM, Kingsman AJ . Effects of stoichiometry of retroviral components on virus production. J Gen Virol 2000; 81: 2195–2202.
  Article CAS PubMed Google Scholar
• Farley DC, Iqball S, Smith JC, Miskin JE, Kingsman SM, Mitrophanous KA . Factors that influence VSV-G pseudotyping and transduction efficiency of lentiviral vectors-in vitro and in vivo implications. J Gene Med 2007; 9: 345–356.
  Article CAS PubMed Google Scholar
• McGrew MJ, Sherman A, Ellard FM, Lillico SG, Gilhooley HJ, Kingsman AJ et al. Efficient production of germline transgenic chickens using lentiviral vectors. EMBO Rep 2004; 5: 728–733.
  Article CAS PubMed PubMed Central Google Scholar
• Rohll JB, Mitrophanous KA, Martin-Rendon E, Ellard FM, Radcliffe PA, Mazarakis ND et al. Design, production, safety, evaluation, and clinical applications of nonprimate lentiviral vectors. Methods Enzymol 2002; 346: 466–500.
  Article CAS PubMed Google Scholar
• Miskin J, Chipchase D, Rohll J, Beard G, Wardell T, Angell D et al. A replication competent lentivirus (RCL) assay for equine infectious anaemia virus (EIAV)-based lentiviral vectors. Gene Therapy 2006; 13: 196–205.
  Article CAS PubMed Google Scholar
• Arnold BA, Hepler RW, Keller PM . One-step fluorescent probe product-enhanced reverse transcriptase assay. Biotechniques 1998; 25: 98–106.
  Article CAS PubMed Google Scholar